Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.

Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.
复制标题

DOI:
10.1084/jem.176.5.1319
复制
发表时间:
1992-11-01
影响因子:
15.3
通讯作者:
SARFATI, M
SARFATI, M
中科院分区:
医学1区
文献类型:
--
作者:
DANCESCU, M;RUBIOTRUJILLO, M;BIRON, G;BRON, D;DELESPESSE, G;SARFATI, M

文献摘要

参考文献

被引文献

相似文献

慢性淋巴细胞白血病(B- cll)的特点是缓慢分裂和长寿命的单克隆B细胞在其分化的中间阶段被阻止。我们之前的研究表明,白细胞介素4 (IL-4)不仅抑制而且阻止B-CLL细胞的增殖。我们在此报告IL-4保护B-CLL细胞免于凋亡(程序性细胞死亡[PCD])。IL-4抑制12例未选择的CLL患者的高纯化B细胞自发和氢化可的松(HC)诱导的PCD,显示出持续的细胞活力和缺乏DNA断裂。IL-1、-2、-3、- 5、-6、-7、肿瘤坏死因子α、转化生长因子β无保护作用。IL-4在体外对细胞凋亡的拯救作用表现为Bcl-2蛋白的表达增加,Bcl-2蛋白是一种直接参与延长体内和体外细胞存活的原癌基因。因此,il -4处理的B-CLL细胞比未刺激的、hc处理的或新鲜的B-CLL细胞表达更多的Bcl-2。此外,一名CLL患者皮下注射IL-4可提高白血病B细胞中Bcl-2蛋白的表达。这些数据可能表明IL-4通过Bcl-2依赖性途径阻止B-CLL细胞凋亡。鉴于我们最近观察到来自B-CLL患者的新鲜T细胞表达IL-4 mRNA,我们提出IL-4通过阻止恶性B细胞的死亡和增殖在CLL疾病的发病机制中起重要作用。
B chronic lymphocytic leukemia (B-CLL) is characterized by the accumulation of slow-dividing and long-lived monoclonal B cells arrested at the intermediate stage of their differentiation. We previously showed that interleukin 4 (IL-4) not only inhibits but also prevents the proliferation of B-CLL cells. We report here that IL-4 protects the B-CLL cells from death by apoptosis (programmed cell death [PCD]). IL-4 inhibits spontaneous and hydrocortisone (HC)-induced PCD of highly purified B cells from 12 unselected CLL patients, as shown by sustained cell viability and lack of DNA fragmentation. IL-1, -2, -3, - 5, -6, -7, tumor necrosis factor alpha, and transforming growth factor beta have no protective effect. The in vitro rescue from apoptosis by IL-4 is reflected by an increased expression of Bcl-2 protein, a proto- oncogene directly involved in the prolongation of cell survival in vivo and in vitro. Hence, IL-4-treated B-CLL cells express significantly more Bcl-2 than unstimulated, HC-treated, or fresh B-CLL cells. Furthermore, subcutaneous injection of IL-4 into one CLL patient enhances Bcl-2 protein expression in the leukemic B cells. These data may suggest that IL-4 prevents apoptosis of B-CLL cells using a Bcl-2- dependent pathway. Given our recent observations that fresh T cells from B-CLL patients express IL-4 mRNA, we propose that IL-4 has an essential role in the pathogenesis of CLL disease, by preventing both the death and the proliferation of the malignant B cells.
DOI: 10.1038/337181a0
发表时间: 1989-01-12
期刊: NATURE
影响因子: 64.8
作者:
SMITH, CA;WILLIAMS, GT;OWEN, JJT
通讯作者: OWEN, JJT
DOI: 10.1172/jci115717
发表时间: 1992-04-01
影响因子: 15.9
作者:
FOURNIER, S;DELESPESSE, G;SARFATI, M
通讯作者: SARFATI, M
DOI: 10.1073/pnas.88.16.6961
发表时间: 1991-08-01
影响因子: 11.1
作者:
HOCKENBERY, DM;ZUTTER, M;KORSMEYER, SJ
通讯作者: KORSMEYER, SJ
DOI: 10.1002/eji.1830210819
发表时间: 1991-08-01
影响因子: 5.4
作者:
LIU, YJ;MASON, DY;MACLENNAN, ICM
通讯作者: MACLENNAN, ICM
白介素4抵消了白介素2诱导的单克隆B细胞增殖。
DOI: 10.1084/jem.168.1.85
发表时间: 1988-07-01
影响因子: 15.3
作者:
Karray, S;DeFrance, T;Merle-Beral, H;Banchereau, J;Debre, P;Galanaud, P
通讯作者: Galanaud, P